Clinical Trial Update: Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating human lysozyme derived from goat milk to prevent graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic and Lymphoid Cell Neoplasm

Drugs mentioned

• Human lysozyme goat milk (human lysozyme)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell Neoplasm | Phase 1 | Status: SUSPENDED